Tenax Other Stockholder Equity from 2010 to 2025

TENX Stock  USD 5.97  0.04  0.67%   
Tenax Therapeutics Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity is likely to outpace its year average in 2025. During the period from 2010 to 2025, Tenax Therapeutics Other Stockholder Equity regression line of annual values had r-squared of  0.84 and arithmetic mean of  227,154,692. View All Fundamentals
 
Other Stockholder Equity  
First Reported
1996-09-30
Previous Quarter
313.5 M
Current Value
405.8 M
Quarterly Volatility
113.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tenax Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tenax Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.3 K, Other Operating Expenses of 8.4 M or Research Development of 3.6 M, as well as many indicators such as Price To Sales Ratio of 141.3 K, Dividend Yield of 3.31 or PTB Ratio of 0.64. Tenax financial statements analysis is a perfect complement when working with Tenax Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tenax Therapeutics Correlation against competitors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.

Latest Tenax Therapeutics' Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Tenax Therapeutics over the last few years. It is Tenax Therapeutics' Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tenax Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Tenax Other Stockholder Equity Regression Statistics

Arithmetic Mean227,154,692
Geometric Mean180,499,700
Coefficient Of Variation41.42
Mean Deviation63,987,567
Median239,572,094
Standard Deviation94,082,708
Sample Variance8851.6T
Range363.2M
R-Value0.92
Mean Square Error1471.2T
R-Squared0.84
Slope18,164,043
Total Sum of Squares132773.3T

Tenax Other Stockholder Equity History

2025368.7 M
2024351.2 M
2023305.4 M
2022291 M
2021282.7 M
2020250.6 M
2019239.9 M

About Tenax Therapeutics Financial Statements

Tenax Therapeutics investors use historical fundamental indicators, such as Tenax Therapeutics' Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tenax Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity351.2 M368.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.